Sign up now to enjoy the discount
A phase 2 randomised controlled trial published in the New England Journal of Medicine (2023) reported substantial weight loss and improvements in glycaemic parameters, though the trial was conducted in a closely monitored clinical setting with defined eligibility criteria
It supports creating brain-targeted B 12 formulations
Additional information Sodium Palmate, Sodium Palm Kernelate, Water, Glycerin, Fragrance, Sodium Chloride, Disodium Cocoamphodiacetate, Titanium Dioxide/Cl 77891, Tetrasodium Etidronate, Tetrasodium EDTA, Butylene Glycol, 1,2-Hexanediol, Glutathione
Storage Publications (6) Journal Impact Factor Most Recent Stem Cell Res Ther Hepatocyte-like cells derived from human induced pluripotent stem cells using small molecules: implications of a transcriptomic study